Fmc Corporation · NYSE:FMC

Fmc — Morgan Stanley Small Cap Chemicals Roundtable 2005

20 slides from Fmc's conference presentation, Dec 2, 2005

  1. Slide 1: FMC Corporation, Morgan Stanley Small Cap Chemicals Roundtable

    Exhibit 99.1 FMC Corporation Morgan Stanley Small Cap Chemicals Roundtable New York, NY November 30, 2005 William G. Walter Chairman, President and CEO

  2. Slide 2: Disclaimer

    Disclaimer Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 • These slides and the accompanying presentation contain “forward-looking statements” that represent management’s best judgment as of the date hereof based on information currently available. Actual results o

  3. Slide 3: FMC Corporation

    FMC Corporation Diversified chemical company with leading market positions in industrial, consumer and agricultural markets globally ($ millions, LTM ending September 30, 2005) FMC Sales: $2,141.7 EBITDA: $420.5 EBITDA Margin: 19.6% Industrial Specialty Agricultural Chemicals Chemicals Products Sale

  4. Slide 4: Disciplined Approach to Unlocking Value

    Disciplined Approach to Unlocking Value Realizing the inherent operating leverage within FMC - Sustained earnings growth >10% per year (1) - Industrial Chemicals recovery in mid-cycle in 2005 - Continued growth in Specialty Chemicals and Agricultural Products Creating greater financial flexibility -

  5. Slide 5: Industrial Chemicals

    Asia 7% Industrial Chemicals Based on 2004 Consolidated Sales of $813.7 million Asia 7% Foret 35% Alkali (Soda ash) Europe/Middle North America 46% East/Africa 50% 35% Peroxygens Latin 19% America 8% #1 North American manufacturer of soda ash and peroxygens Backward integration into natural resource

  6. Slide 6: Industrial Chemicals Financial Performance

    Industrial Chemicals Financial Performance Earnings growth of 45% expected in 2005 driven by higher selling prices, partially offset by higher energy, raw material and transportation costs 200 20% 150 $151 15% $133 $130 $124 100 $94 10% 50 5% 0 0% 2001 2002 2003 2004 LTM 9/30/05 EBITDA Capital Spend

  7. Slide 7: Industrial Chemicals' Focus

    Industrial Chemicals’ Focus Managing for cash generation Near-term sales growth – Higher selling prices for soda ash – Incremental soda ash capacity addition at Granger – US and European peroxides producers have announced price increases Margin expansion - Working to offset rising energy, raw materi

  8. Slide 8: Growth Franchises in Specialty Chemicals

    Growth Franchises in Specialty Chemicals Based on 2004 Consolidated Sales of $538.0 million Asia 15% Lithium 28% North America Europe/Middle 41% BioPolymer East/Africa 72% 36% Latin America 8% BioPolymer: • Adds structure, texture and stability to food • Acts as a binder & disintegrant for dry table

  9. Slide 9: Specialty Chemicals Financial Performance

    Specialty Chemicals Financial Performance 2005 earnings growth expected to be approximately 15%, driven by increased selling prices and productivity improvement 160 30% $140 $132 $129 $122 28% $116 120 26% 80 24% 40 22% 0 20% 2001 2002 2003 2004 LTM 9/30/05 EBITDA Capital Spending EBITDA Margin 8

  10. Slide 10: Specialty Chemicals Focus

    Specialty Chemicals Focus Growing existing core business – Maintaining key positions with category leading customers – Shifting resources toward faster growing segments – Expanding presence in rapidly growing emerging markets Commercializing new technology platforms Managing maturing segments for im

  11. Slide 11: Agricultural Products

    Agricultural Products Based on 2004 Consolidated Sales of $703.5 million Asia 13% Herbicides 25% Europe/ Middle Latin America East/Africa 36% Fungicides 2% 16% Insecticides 73% North America 35% Strong niche positions in the Americas, Europe and Asia Proprietary, branded insecticides and herbicides

  12. Slide 12: Agricultural Products Financial Performance

    Agricultural Products Financial Performance Earnings growth of 5% expected in 2005, reflecting higher sales and lower manufacturing costs partially offset by lower bifenthrin pricing and higher raw materials costs. 175 $160 25 $148 150 $114 $111 20 125 $101 $99 100 15 75 10 50 5 25 0 0 2000 2001 200

  13. Slide 13: Agricultural Products' Focus

    Agricultural Products’ Focus Creating competitive advantage through innovation – Investing 10% of sales in R&D – In-licensing products & technologies that complement segment strategies Driving near-term sales growth – Label expansions and new formulations in crop and non-crop segments – In-licensed

  14. Slide 14: FMC in Summary

    FMC in Summary Great businesses, each with EBITDA of at least $140 million Double digit earnings growth - Earnings leverage in Industrial Chemicals - Continued growth in Specialty Chemicals and Ag Products Strong financial position - Robust and growing EBITDA - Substantial decline in unusual demands

  15. Slide 15: FMC Remains Significantly Undervalued

    FMC Remains Significantly Undervalued EV/2006E EBITDA 8.1 7.7 7.3 7.4 7.1 6.8 6.0 6.0 6.1 5.8 5.5 4.4 4.2 3.8 OLN CEM LYO FMC FUL ARJ HPC MTX RPM CBT LZ CYT ALB VAL Source: Bloomberg and Thomson First Call 14

  16. Slide 16: FMC Corporation

    *********** *********** FMC Corporation ***********

  17. Slide 17: Non-GAAP Financial Terms

    Non-GAAP Financial Terms These slides contain certain “non-GAAP financial terms” which are defined below. In addition, we have provided reconciliations of non-GAAP terms to the closest GAAP term in the appendix of this presentation. EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortizat

  18. Slide 18: Segment Financial Terms

    Segment Financial Terms These slides contain references to segment financial items which are presented in detail in Note 18 of FMC’s 2004 Form 10-K. Some of the segment financial terms are “non-GAAP financial terms” and are defined below. In addition, we have provided reconciliations of non-GAAP ter

  19. Slide 19: EBITDA Reconciliation: LTM 9/30/05

    EBITDA Reconciliation: LTM 9/30/05 Reconciliation of LTM 9/301/2005 consolidated income from continuing operations before income taxes (a GAAP measure) to LTM 9/30/2005 EBITDA (a Non-GAAP measure) (Unaudited, in $ millions) LTM 9/30/2005 Income (loss) from continuing operations before income taxes $

  20. Slide 20: Segment EBITDA Reconciliation

    Segment EBITDA Reconciliation Reconciliation of LTM 9/30/05 segment operating profit (a GAAP measure) to LTM 9/30/05 EBITDA (a Non-GAAP measure) (Unaudited, in millions) Industrial Specialty Agricultural Segment Chemicals Chemicals Products LTM 9/30/05 segment operating profit (GAAP) $82.6 $106.9 $1

FMC — Morgan Stanley Small Cap Chemicals Roundtable 2005 on 6ix